Change language dansk English suomi svenska

Generate Estimates Confirm Cancel Hide empty rows Show hidden rows DummyText

Tandlægeselskabet Godt Smil Frederikshavn ApS Estimate generation in progress, please wait... 0%

Quicksearch from your own companies XBRLDenmark Analyst: XBRLDenmark

Loading... Loading... Loading... Loading...   Loading...

1000.0 Bankruptcy Risk  2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024 2024/12 2025e N/A 2026e N/A Bankruptcy risk for industry   0.5% 0.5% 0.5% 0.5% 0.5% 0.5% 0.5% 0.5%   Bankruptcy risk   8.5% 4.3% 4.3% 5.4% 12.0% 8.9% 13.2% 13.2%   Credit score (0-100)   30 48 46 41 19 28 17 17   Credit rating   BB BBB BBB BBB BB BB BB BB   Credit limit (kDKK)   0.0 0.0 0.0 0.0 0.0 0.0 -0.0 -0.0   How are these values calculated?   View the automatically generated explanation of bankruptcy risk 1000.0 Income statement (kDKK)  2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024 2024/12 2025e N/A 2026e N/A Net sales   0 0 0 0 0 0 0 0   Gross profit   7,533 7,367 9,818 6,859 7,038 8,397 0.0 0.0   EBITDA   77.7 523 1,522 65.6 216 950 0.0 0.0   EBIT   -430 54.5 1,049 -418 -500 225 0.0 0.0   Pre-tax profit (PTP)   -512.0 -11.1 1,009.2 -483.7 -615.5 87.1 0.0 0.0   Net earnings   -399.4 -9.4 786.9 -378.1 -480.1 67.9 0.0 0.0   Pre-tax profit without non-rec. items   -512 -11.1 1,009 -484 -616 87.1 0.0 0.0     See the entire income statement 1000.0 Balance sheet (kDKK)  2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024 2024/12 2025e N/A 2026e N/A Tangible assets total   1,735 1,447 1,225 1,185 1,432 952 0.0 0.0   Shareholders equity total   191 181 968 340 -140 -71.9 -122 -122   Interest-bearing liabilities   0.0 2,322 781 1,972 188 188 164 164   Balance sheet total (assets)   4,688 4,360 3,828 3,568 3,468 2,971 42.5 42.5   Net Debt   -151 2,048 485 1,765 130 -6.1 164 164     See the entire balance sheet 1000.0 Volume  2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024 2024/12 2025e N/A 2026e N/A Net sales   0 0 0 0 0 0 0 0   Net sales growth   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Gross profit   7,533 7,367 9,818 6,859 7,038 8,397 0.0 0.0   Gross profit growth   51.5% -2.2% 33.3% -30.1% 2.6% 19.3% -100.0% 0.0%   Employees   11 10 12 11 12 11 0 0   Employee growth %   22.2% -9.1% 20.0% -8.3% 9.1% -8.3% -100.0% 0.0%   Employee expenses   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   Balance sheet total (assets)   4,688 4,360 3,828 3,568 3,468 2,971 43 43   Balance sheet change%   -0.1% -7.0% -12.2% -6.8% -2.8% -14.3% -98.6% 0.0%   Added value   77.7 522.5 1,521.9 65.6 -17.1 950.0 0.0 0.0   Added value %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Investments   -981 -921 -861 -688 -635 -1,370 -952 0   Net sales trend   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   EBIT trend   -4.0 1.0 2.0 -1.0 -2.0 1.0 0.0 0.0   1000.0 Profitability  2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024 2024/12 2025e N/A 2026e N/A EBITDA %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   EBIT %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   EBIT to gross profit (%)   -5.7% 0.7% 10.7% -6.1% -7.1% 2.7% 0.0% 0.0%   Net Earnings %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Profit before depreciation and extraordinary items %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Pre tax profit less extraordinaries %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   ROA %   -9.0% 1.4% 25.8% -11.2% -13.7% 7.0% 0.0% 0.0%   ROI %   -95.7% 4.0% 43.4% -18.9% -39.4% 123.8% 0.0% 0.0%   ROE %   -102.3% -5.0% 136.9% -57.8% -25.2% 2.1% 0.0% 0.0%   1000.0 Solidity  2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024 2024/12 2025e N/A 2026e N/A Equity ratio %   4.2% 4.3% 26.9% 10.0% -4.0% -2.4% -74.2% -74.2%   Relative indebtedness %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Relative net indebtedness %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Net int. bear. debt to EBITDA, %   -193.8% 391.9% 31.9% 2,689.1% 60.1% -0.6% 0.0% 0.0%   Gearing %   0.0% 1,279.8% 80.7% 579.5% -134.1% -260.7% -134.9% -134.9%   Net interest   0 0 0 0 0 0 0 0   Financing costs %   0.0% 6.3% 2.9% 5.1% 11.4% 77.3% 0.0% 0.0%   1000.0 Liquidity  2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024 2024/12 2025e N/A 2026e N/A Quick Ratio   0.4 0.4 0.6 0.5 0.4 0.5 0.0 0.0   Current Ratio   0.4 0.5 0.7 0.6 0.5 0.7 0.0 0.0   Cash and cash equivalent   150.7 274.3 296.4 207.0 57.5 193.6 0.0 0.0   1000.0 Capital use efficiency  2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024 2024/12 2025e N/A 2026e N/A Trade debtors turnover (days)   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   Trade creditors turnover (days)   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   Current assets / Net sales %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Net working capital   -2,455.9 -1,815.5 -642.5 -1,058.3 -1,404.4 -868.5 -82.2 -82.2   Net working capital %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   1000.0 Employee efficiency  2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024 2024/12 2025e N/A 2026e N/A Net sales / employee   0 0 0 0 0 0 0 0   Added value / employee   7 52 127 6 -1 86 0 0   Employee expenses / employee   0 0 0 0 0 0 0 0   EBITDA / employee   7 52 127 6 18 86 0 0   EBIT / employee   -39 5 87 -38 -42 20 0 0   Net earnings / employee   -36 -1 66 -34 -40 6 0 0